ipilimumab,nivolumab
bms
['ipilimumab', 'nivolumab', 'nivo', 'radio']
jiayi huang, md, presents a phase i/ii study of nivolumab w/ or without ipilimumab in combination w/ multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma poster (#48) at 8:00am in mccormick, hall a. #asco22 
A National Cancer Institute Comprehensive Cancer Center and member of the National Comprehensive Cancer Network